DK1276501T3 - Fremgangsmåde til behandling af tumorer under anvendelse af fotodynamisk terapi - Google Patents
Fremgangsmåde til behandling af tumorer under anvendelse af fotodynamisk terapiInfo
- Publication number
- DK1276501T3 DK1276501T3 DK01928938T DK01928938T DK1276501T3 DK 1276501 T3 DK1276501 T3 DK 1276501T3 DK 01928938 T DK01928938 T DK 01928938T DK 01928938 T DK01928938 T DK 01928938T DK 1276501 T3 DK1276501 T3 DK 1276501T3
- Authority
- DK
- Denmark
- Prior art keywords
- photodynamic therapy
- treating tumors
- tumor
- bearing
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19954500P | 2000-04-25 | 2000-04-25 | |
PCT/US2001/013616 WO2001080888A2 (en) | 2000-04-25 | 2001-04-25 | Method for treatment of tumors using photodynamic therapy |
Publications (2)
Publication Number | Publication Date |
---|---|
DK1276501T3 true DK1276501T3 (da) | 2006-04-24 |
DK1276501T5 DK1276501T5 (da) | 2007-02-26 |
Family
ID=22737985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK01928938T DK1276501T5 (da) | 2000-04-25 | 2001-04-25 | Fremgangsmåde til behandling af tumorer under anvendelse af fotodynamisk terapi |
Country Status (10)
Country | Link |
---|---|
US (2) | US20020041864A1 (da) |
EP (1) | EP1276501B9 (da) |
AT (1) | ATE313334T1 (da) |
AU (2) | AU5574001A (da) |
CA (1) | CA2407336A1 (da) |
DE (1) | DE60116075T4 (da) |
DK (1) | DK1276501T5 (da) |
ES (1) | ES2254408T4 (da) |
PT (1) | PT1276501E (da) |
WO (1) | WO2001080888A2 (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040110846A1 (en) * | 2001-01-30 | 2004-06-10 | Beatrice Leveugle | Perylenequinones for use with immunotherapy agents |
IL157946A0 (en) * | 2001-04-02 | 2004-03-28 | Genentech Inc | Combination therapy |
AU2003226082A1 (en) * | 2002-03-25 | 2003-11-11 | The General Hospital Corporation | Methods of adjuvant photodynamic therapy to enhance radiation sensitization |
WO2004092195A2 (en) * | 2003-04-09 | 2004-10-28 | Administrators Of The Tulane Educational Fund | Dendritic cell binding proteins and uses thereof |
CA2615510A1 (en) * | 2005-08-10 | 2007-02-15 | Quest Pharmatech Inc. | Perylenequinone derivatives and uses thereof |
US8454991B2 (en) * | 2006-07-24 | 2013-06-04 | Quest Pharmatech Inc. | Method and device for photodynamic therapy |
US20100255080A1 (en) * | 2009-04-02 | 2010-10-07 | Sesvalia Usa, Llc | Liposomal ALA pharmaceutical and cosmeceutical compositions and methods of treatment |
EP2718457A4 (en) * | 2011-06-06 | 2014-12-24 | Immungene Inc | GENETICALLY MODIFIED FUSION MOLECULES LIGAND TNFSF-ANTIBODY ELEMENT |
JP2022512540A (ja) * | 2018-08-29 | 2022-02-07 | シャタック ラボ,インコーポレイテッド | Flt3l系キメラタンパク質 |
AU2020294700A1 (en) * | 2019-06-17 | 2022-02-03 | Renovaro Biosciences Inc. | Allogeneic T-cell-based HIV vaccine to induce cellular and humoral immunity |
EP4329786A1 (en) | 2021-04-30 | 2024-03-06 | KaliVir Immunotherapeutics, Inc. | Oncolytic viruses for modified mhc expression |
BR112023026235A2 (pt) * | 2021-06-17 | 2024-03-05 | Kalivir Immunotherapeutics Inc | Proteínas de fusão tnfsf-l e seus usos |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5981724A (en) * | 1991-10-25 | 1999-11-09 | Immunex Corporation | DNA encoding CD40 ligand, a cytokine that binds CD40 |
US5962406A (en) * | 1991-10-25 | 1999-10-05 | Immunex Corporation | Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
EP0615451B1 (en) * | 1992-05-26 | 2005-12-07 | Immunex Corporation | Novel cytokine that binds cd30 |
JPH09507074A (ja) * | 1993-12-23 | 1997-07-15 | イミュネックス・コーポレーション | Cd40を発現する腫瘍細胞を特徴とする疾患の予防又は治療方法 |
US6495129B1 (en) * | 1994-03-08 | 2002-12-17 | Human Genome Sciences, Inc. | Methods of inhibiting hematopoietic stem cells using human myeloid progenitor inhibitory factor-1 (MPIF-1) (Ckbeta-8/MIP-3) |
US7361330B2 (en) * | 1995-10-04 | 2008-04-22 | Immunex Corporation | Methods of using flt3-ligand in the treatment of fibrosarcoma |
SI9620116A (sl) * | 1995-10-04 | 1999-08-31 | Immunex Corporation | Stimulatorni faktor dendritičnih celic |
US6146409A (en) * | 1996-05-20 | 2000-11-14 | Bergein F. Overholt | Therapeutic methods and devices for irradiating columnar environments |
NZ333607A (en) * | 1996-07-10 | 2000-08-25 | Immunex Corp | Method of stimulating the immune system by transfecting dendritic cells |
US6291661B1 (en) * | 1998-07-02 | 2001-09-18 | Immunex Corporation | flt3-L mutants and method of use |
WO2000051638A1 (en) * | 1999-02-26 | 2000-09-08 | Qlt Phototherapeutics Inc. | Photodynamic therapy in combination with apoptosis inducing factors |
US6756141B2 (en) * | 2001-04-17 | 2004-06-29 | Southwest Research Institute | Three-electrode fuel cell |
-
2001
- 2001-04-25 WO PCT/US2001/013616 patent/WO2001080888A2/en active IP Right Grant
- 2001-04-25 US US09/842,745 patent/US20020041864A1/en not_active Abandoned
- 2001-04-25 DK DK01928938T patent/DK1276501T5/da active
- 2001-04-25 AU AU5574001A patent/AU5574001A/xx active Pending
- 2001-04-25 AT AT01928938T patent/ATE313334T1/de not_active IP Right Cessation
- 2001-04-25 PT PT01928938T patent/PT1276501E/pt unknown
- 2001-04-25 CA CA002407336A patent/CA2407336A1/en not_active Abandoned
- 2001-04-25 DE DE60116075T patent/DE60116075T4/de not_active Expired - Fee Related
- 2001-04-25 EP EP01928938A patent/EP1276501B9/en not_active Expired - Lifetime
- 2001-04-25 ES ES01928938T patent/ES2254408T4/es not_active Expired - Lifetime
- 2001-04-25 AU AU2001255740A patent/AU2001255740B2/en not_active Ceased
-
2004
- 2004-11-12 US US10/986,964 patent/US20050129689A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001080888A3 (en) | 2002-08-29 |
DK1276501T5 (da) | 2007-02-26 |
CA2407336A1 (en) | 2001-11-01 |
AU5574001A (en) | 2001-11-07 |
DE60116075T4 (de) | 2007-06-06 |
EP1276501B1 (en) | 2005-12-21 |
DE60116075D1 (de) | 2006-01-26 |
PT1276501E (pt) | 2006-05-31 |
EP1276501B9 (en) | 2007-01-24 |
DE60116075T2 (de) | 2006-08-31 |
ES2254408T3 (es) | 2006-06-16 |
AU2001255740B2 (en) | 2006-03-16 |
EP1276501A2 (en) | 2003-01-22 |
WO2001080888A2 (en) | 2001-11-01 |
ES2254408T4 (es) | 2007-10-01 |
US20050129689A1 (en) | 2005-06-16 |
ATE313334T1 (de) | 2006-01-15 |
US20020041864A1 (en) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20022065D0 (no) | Terapeutisk anvendelse | |
DE60037394D1 (de) | VERWENDUNG VON p53 INHIBITOREN ZUR BEHANDLUNG VON NEBENERSCHEINUNGEN BEI DER KREBSTHERAPIE | |
DK1276501T3 (da) | Fremgangsmåde til behandling af tumorer under anvendelse af fotodynamisk terapi | |
WO2001082961A3 (en) | Methods for treating bone tumors | |
DK1827500T3 (da) | Pegyleret liposomal doxorubicin i kombination med ecteinescidin 743 | |
BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
WO2002066044A3 (en) | Method for dendritic cells based immunotherapy of tumors using combination therapy | |
WO2005092073A3 (en) | Use of anti-alpha5beta1 antibodies to inhibit cancer cell proliferation | |
HK1050860A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
EP1605847A4 (en) | PHOTODYNAMIC THERAPY PROVIDED AGAINST ANTIBODIES | |
DK1689404T3 (da) | Kombination af et-743 med 5-fluoracil-prodrugs til behandling af cancer | |
WO2000057911A3 (en) | Hapten-conjugated mammalian cells and methods of making and using thereof | |
IL141550A0 (en) | Methods and compositions for the prevention or treatment of cancer | |
HK1029944A1 (en) | Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway | |
DK1185279T3 (da) | Midler til behandling af maligne sygdomme ved anvendelse af proteinet YB-1 | |
TW200724158A (en) | Combination therapy in the treatment of cancer | |
DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
PA8453601A1 (es) | Inhibidores de la farnesil transferasa combinados con inhibidores de la hmg coa reductasa para tratamiento del cancer | |
WO2005041860A3 (en) | Stem cells for use in locating and targeting tumor cells | |
HK1074840A1 (en) | Novel dithiolopyrrolones with therapeutic activity | |
HK1079116A1 (en) | Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy | |
ATE537838T1 (de) | Kombinationstherapie mit kloretazin(tm) | |
WO2005006947A3 (en) | Cells for use in locating and targeting tumor cells | |
EA200600987A1 (ru) | Применение сирамезина в лечении злокачественных опухолей | |
WO2003059334A3 (en) | Gemcitabine in the treatment of smallpox |